Intronic VUS variant
Hello!
In a deaf sibling, we have found an intronic homozygote VUS variant (a point mutation), which is more than 100 bases away from the gene's splice sites. (NGS results have been confirmed by sanger sequencing) How can we support the pathogenicity of this variant in silico ?
• 967 views
•
link
written
by
Fatemeh Nabizadeh •
0 answers
No answers yet.
Log in to answer this question.
More posts like this
-
Tool: VarViz: A Free, Open-Source Web Application for Protein-Centric Missense Variant Visualizatio…
written by Agasthya •
-
A criteria to classify probes based on the DP of its bases
written by Manuel •
-
Prioritizing structural variants and CNV
written by jan
-
Bowtie2 MAPQ difference using local vs end-to-end alignment
written by polys •
-
Update: Requesting detailed system requirements/installation instructions for ShapeIt and extractPI…
written by bpierson •
-
Benefits of 150 bp reads over 100 bp reads in RNA-seq
written by poisonAlien
-
Lack of consensus between NGS & Sanger sequencing on indels/mutations
written by alons
-
Variant Filtration And Surprising Results
written by ao.carson •
-
Errors In Dbsnp
written by Pi •
-
Rip-Seq: How Do You Determine What'S Good Coverage?
written by Jason
